Loading clinical trials...
Loading clinical trials...
The key molecular changes in the progression of glioma are closely related to tumor heterogeneity, pathological grade, precision treatment and prognosis of glioma. At present, a visually quantitative ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tongji Hospital
NCT04196413 · Glioma of Spinal Cord, Glioma of Brainstem
NCT02509442 · Low Grade Glioma of Brain
NCT03213002 · Glioblastoma Multiforme (GBM), Glioblastoma, and more
NCT03849430 · Glioma of Brain
NCT03935685 · Glioma of Brain
Zhenxiong Wang
Wuhan, Choose A State Or Province
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions